Emerald Mutual Fund Advisers Trust’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-307,723
Closed -$1.27M 350
2020
Q3
$1.27M Sell
307,723
-314,326
-51% -$1.3M 0.06% 156
2020
Q2
$1.59M Buy
622,049
+25,000
+4% +$64K 0.08% 145
2020
Q1
$1.73M Buy
597,049
+40,022
+7% +$116K 0.11% 140
2019
Q4
$2.11M Sell
557,027
-51,992
-9% -$197K 0.09% 171
2019
Q3
$3.12M Sell
609,019
-7,645
-1% -$39.1K 0.14% 157
2019
Q2
$3.82M Buy
616,664
+51,345
+9% +$318K 0.15% 150
2019
Q1
$4.02M Hold
565,319
0.16% 158
2018
Q4
$4.83M Sell
565,319
-61,422
-10% -$525K 0.23% 140
2018
Q3
$12.5M Buy
626,741
+76,387
+14% +$1.53M 0.42% 96
2018
Q2
$14.2M Buy
550,354
+17,877
+3% +$462K 0.51% 79
2018
Q1
$12.7M Buy
532,477
+2,540
+0.5% +$60.7K 0.5% 70
2017
Q4
$18M Hold
529,937
0.71% 46
2017
Q3
$11.2M Sell
529,937
-41,852
-7% -$886K 0.47% 76
2017
Q2
$10M Hold
571,789
0.44% 81
2017
Q1
$10M Hold
571,789
0.46% 75
2016
Q4
$9.66M Hold
571,789
0.46% 77
2016
Q3
$9.38M Buy
571,789
+11,910
+2% +$195K 0.48% 84
2016
Q2
$8.48M Buy
559,879
+21,301
+4% +$323K 0.48% 82
2016
Q1
$7.79M Buy
538,578
+86,895
+19% +$1.26M 0.44% 91
2015
Q4
$12.8M Buy
451,683
+89,371
+25% +$2.53M 0.68% 59
2015
Q3
$6.07M Buy
362,312
+45,622
+14% +$764K 0.4% 94
2015
Q2
$8.3M Sell
316,690
-9,840
-3% -$258K 0.64% 61
2015
Q1
$5.72M Buy
326,530
+114,656
+54% +$2.01M 0.47% 81
2014
Q4
$3.68M Buy
211,874
+38,654
+22% +$671K 0.32% 97
2014
Q3
$3.23M Buy
173,220
+66,999
+63% +$1.25M 0.31% 103
2014
Q2
$1.94M Buy
+106,221
New +$1.94M 0.18% 125